featured
First-in-Human Study of MTA-Cooperative PRMT5 Inhibitor AMG 193 in Patients With MTAP-Deleted Solid Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration
Ann. Oncol 2024 Sep 16;[EPub Ahead of Print], J Rodon, H Prenen, A Sacher, M Villalona-Calero, N Penel, A El Helali, S Rottey, N Yamamoto, F Ghiringhelli, ME Goebeler, T Doi, S Postel-Vinay, CC Lin, C Liu, CH Chuang, K Keyvanjah, T Eggert, BH O'NeilFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.